Takuma Ishizaki Selected Research

Hemorrhage

1/2023	[Coagulative complete remission following early gastric cancer resection in a patient with steroid-resistant acquired hemophilia A and nephrotic syndrome].
1/2022	[Spontaneous disappearance of the inhibitor during emicizumab therapy in a patient with mild hemophilia A].
4/2020	Overshoot of FVIII activity in patients with acquired hemophilia A who achieve complete remission.
1/2020	[Successful management of acquired factor V deficiency developing shortly after induction of hemodialysis].
1/2019	[Recurrence of acquired factor V inhibitor after four years of remission].
7/2017	Clinical characteristics and outcomes of acquired hemophilia A: experience at a single center in Japan.
1/2017	Successful Management of a Patient with Autoimmune Hemorrhaphilia due to Anti-Factor XIII/13 Antibodies Complicated by Pulmonary Thromboembolism.
4/2016	[Remission of acquired hemophilia A following radiation therapy for esophageal cancer].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takuma Ishizaki Research Topics

Disease

8	Hemorrhage 01/2023 - 04/2016
7	Hemophilia A (Haemophilia) 01/2023 - 04/2016
6	Neoplasms (Cancer) 04/2021 - 12/2015
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 11/2019
3	Infections 01/2023 - 01/2017
3	Disease Progression 01/2023 - 12/2015
3	Thrombosis (Thrombus) 01/2020 - 01/2017
2	Lymphoma (Lymphomas) 12/2022 - 12/2015
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2021 - 01/2020
2	Dehydration (Water Stress) 01/2020 - 01/2020
2	Rupture 01/2019 - 03/2016
2	Multiple Myeloma 01/2019 - 11/2017
2	Wounds and Injuries (Trauma) 01/2018 - 12/2009
2	acquired Thrombotic thrombocytopenic purpura 01/2017 - 03/2016
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2023
1	Stomach Neoplasms (Stomach Cancer) 01/2023
1	Edema (Dropsy) 01/2023
1	Hemorrhagic Shock 01/2023
1	Necrosis 12/2022
1	Evans Syndrome 01/2022
1	Broca Aphasia (Expressive Aphasia) 01/2022
1	Epistaxis (Nosebleed) 01/2022
1	Hematoma 01/2022
1	Proteinuria 11/2020
1	Myeloid Sarcoma (Chloroma) 02/2020
1	Factor V Deficiency 01/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2020
1	Wound Infection (Wound Infections) 01/2020
1	Femoral Fractures (Femoral Fracture) 01/2020
1	Plasma Cell Neoplasms 01/2019
1	Hemolytic Anemia 01/2019
1	Myocardial Infarction 01/2019
1	Paraproteinemias (Monoclonal Gammopathy) 01/2019
1	Monoclonal Gammopathy of Undetermined Significance 01/2019
1	Kidney Diseases (Kidney Disease) 01/2019
1	Heart Failure 01/2019
1	Down Syndrome (Down's Syndrome) 01/2019
1	Neoplasm Metastasis (Metastasis) 11/2017
1	Genomic Instability 08/2017
1	Ataxia Telangiectasia (Louis Bar Syndrome) 08/2017
1	B-Cell Lymphoma (Lymphoma, B Cell) 08/2017
1	Neutropenia 01/2017
1	Liver Diseases (Liver Disease) 01/2017
1	Pulmonary Embolism 01/2017
1	Thrombotic Thrombocytopenic Purpura 01/2017
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2017
1	Hemostatic Disorders 01/2017
1	Renal Cell Carcinoma (Grawitz Tumor) 04/2016
1	Esophageal Neoplasms (Esophageal Cancer) 04/2016

Drug/Important Bio-Agent (IBA)

8	AutoantibodiesIBA 04/2020 - 03/2016
5	SteroidsIBA 01/2023 - 01/2017
5	Rituximab (Mabthera)FDA Link 01/2019 - 12/2015
4	Factor VIII (Coagulation Factor VIII)IBA 01/2023 - 04/2016
2	Prednisolone (Predate)FDA LinkGeneric 01/2023 - 04/2016
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2020
2	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 04/2021 - 12/2015
2	Dasatinib (BMS 354825)FDA Link 11/2020 - 06/2014
2	Tyrosine Kinase InhibitorsIBA 11/2020 - 06/2014
2	Factor V (Coagulation Factor V)IBA 01/2020 - 01/2019
2	CytokinesIBA 01/2019 - 12/2009
2	thiamine triphosphorate (TTP)IBA 01/2017 - 03/2016
1	recombinant FVIIa (rFVIIa)FDA Link 01/2022
1	Hemostatics (Antihemorrhagics)IBA 01/2022
1	emicizumabIBA 01/2022
1	bosutinibIBA 11/2020
1	Poly (ADP-Ribose) Polymerase-1IBA 06/2020
1	IntegrinsIBA 02/2020
1	Laminin (Merosin)IBA 02/2020
1	AnticoagulantsIBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Abscisic AcidIBA 01/2020
1	Farnesyltranstransferase (Farnesyltransferase)IBA 01/2020
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2019
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2019
1	Methimazole (Thiamazole)FDA LinkGeneric 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Potassium Iodide (Pima)FDA Link 01/2019
1	activin AIBA 01/2019
1	Peptides (Polypeptides)IBA 01/2018
1	Long Noncoding RNAIBA 11/2017
1	Phosphotransferases (Kinase)IBA 08/2017
1	Interleukin-6 (Interleukin 6)IBA 08/2017
1	Immunoglobulins (Immunoglobulin)IBA 08/2017
1	Factor XIII (Coagulation Factor XIII)IBA 01/2017
1	AntibodiesIBA 01/2017
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2017
1	Inosine Triphosphate (ITP)IBA 04/2016

Therapy/Procedure

7	Therapeutics 01/2022 - 04/2016
5	Cell Transplantation 11/2021 - 11/2019
3	Drug Therapy (Chemotherapy) 12/2022 - 07/2013
2	Platelet Transfusion (Blood Platelet Transfusions) 01/2022 - 03/2016
2	Plasma Exchange 01/2017 - 01/2017
1	Tooth Extraction (Tooth Extractions) 01/2022
1	Plasmapheresis 01/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021
1	Debridement 01/2020
1	Replacement Arthroplasty 01/2020
1	Renal Dialysis (Hemodialysis) 01/2020
1	Cesarean Section (Caesarean Section) 01/2019
1	Radiotherapy 04/2016